UiPath Inc.

BMV:PATH * Stock Report

Market Cap: Mex$160.8b

UiPath Valuation

Is PATH * undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of PATH * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: PATH * (MX$289.5) is trading above our estimate of fair value (MX$284.33)

Significantly Below Fair Value: PATH * is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for PATH *?

Key metric: As PATH * is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for PATH *. This is calculated by dividing PATH *'s market cap by their current revenue.
What is PATH *'s PS Ratio?
PS Ratio5.6x
SalesUS$1.38b
Market CapUS$7.80b

Price to Sales Ratio vs Peers

How does PATH *'s PS Ratio compare to its peers?

The above table shows the PS ratio for PATH * vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average19.6x
4704 Trend Micro
4.1x5.7%JP¥1.1t
301269 Empyrean Technology
60.4x27.0%CN¥69.6b
CVLT Commvault Systems
8.4x10.4%US$7.8b
TENB Tenable Holdings
5.7x9.3%US$5.2b
PATH * UiPath
5.6x9.7%Mex$7.8b

Price-To-Sales vs Peers: PATH * is good value based on its Price-To-Sales Ratio (5.6x) compared to the peer average (20.2x).

Price to Sales Ratio vs Industry

How does PATH *'s PS Ratio compare vs other companies in the Global Software Industry?

244 CompaniesPrice / SalesEstimated GrowthMarket Cap
No. of Companies244PS02.85.68.411.214+
244 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: PATH * is expensive based on its Price-To-Sales Ratio (5.6x) compared to the Global Software industry average (3.2x).

Price to Sales Ratio vs Fair Ratio

What is PATH *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

PATH * PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio5.6x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate PATH *'s Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst PATH * forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentMex$289.50
Mex$314.31
+8.6%
9.7%Mex$384.56Mex$263.12n/a17
Nov ’25Mex$249.00
Mex$307.88
+23.6%
9.7%Mex$376.69Mex$257.73n/a17
Oct ’25Mex$254.00
Mex$315.18
+24.1%
9.9%Mex$379.86Mex$269.90n/a17
Sep ’25Mex$248.05
Mex$283.76
+14.4%
11.8%Mex$355.25Mex$243.07n/a17
Aug ’25Mex$220.00
Mex$290.09
+31.9%
12.8%Mex$356.27Mex$243.77n/a17
Jul ’25Mex$235.00
Mex$298.38
+27.0%
19.2%Mex$478.70Mex$239.35n/a17
Jun ’25Mex$205.50
Mex$271.45
+32.1%
20.2%Mex$441.11Mex$203.59n/a17
May ’25Mex$325.00
Mex$459.00
+41.2%
8.3%Mex$526.74Mex$395.05n/a20
Apr ’25Mex$370.00
Mex$469.06
+26.8%
8.3%Mex$536.36Mex$402.27n/a20
Mar ’25Mex$403.23
Mex$426.20
+5.7%
13.3%Mex$511.44Mex$289.82n/a18
Feb ’25Mex$414.36
Mex$407.55
-1.6%
15.2%Mex$505.93Mex$286.69n/a18
Jan ’25Mex$440.00
Mex$403.01
-8.4%
15.1%Mex$509.66Mex$288.81n/a18
Dec ’24Mex$436.00
Mex$405.08
-7.1%
14.7%Mex$515.91Mex$292.35n/a18
Nov ’24n/a
Mex$343.30
0%
15.4%Mex$495.03Mex$273.12Mex$249.0018
Oct ’24n/a
Mex$343.30
0%
15.4%Mex$495.03Mex$273.12Mex$254.0018
Sep ’24Mex$275.00
Mex$322.97
+17.4%
12.7%Mex$426.28Mex$272.82Mex$248.0517
Aug ’24Mex$290.90
Mex$334.00
+14.8%
13.0%Mex$442.21Mex$283.01Mex$220.0017
Jul ’24n/a
Mex$334.00
0%
13.0%Mex$442.21Mex$283.01Mex$235.0017
Jun ’24Mex$314.00
Mex$334.00
+6.4%
13.0%Mex$442.21Mex$283.01Mex$205.5017
May ’24n/a
Mex$353.78
0%
15.1%Mex$494.45Mex$287.68Mex$325.0017
Apr ’24n/a
Mex$354.25
0%
15.3%Mex$495.62Mex$270.34Mex$370.0016
Mar ’24n/a
Mex$327.37
0%
22.7%Mex$524.42Mex$228.84Mex$403.2318
Feb ’24Mex$271.00
Mex$327.37
+20.8%
22.7%Mex$524.42Mex$228.84Mex$414.3618
Jan ’24n/a
Mex$344.86
0%
21.4%Mex$543.64Mex$237.23Mex$440.0018
Dec ’23n/a
Mex$335.63
0%
22.0%Mex$531.64Mex$231.99Mex$436.0018
Nov ’23n/a
Mex$353.10
0%
23.1%Mex$600.79Mex$240.32n/a19

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

Global Dominion Access

€400.4m

Provides integral services for business process efficiency and sustainability worldwide.

DOM N

€57.80

7D

0%

1Y

n/a

Open Text

US$10.1b

Provides information management software and solutions.

OTEX N

US$777.91

7D

0%

1Y

-6.6%

Amdocs

US$10.0b

Through its subsidiaries, provides software and services worldwide.

DOX N

US$1,456.43

7D

0%

1Y

n/a